Form 4: Hologic Director Stacey D. Stewart Reports Acquisition of Stock and Stock Options

Director Stacey D. Stewart reports acquisition of common stock and stock options in Hologic Inc.

Summary

• On March 7, 2024, Stacey D. Stewart, a director of Hologic Inc., reported acquiring 1,572 shares of common stock.
• These shares were acquired in the form of restricted stock units (RSUs) that vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock on a one-for-one basis.
• Stewart also acquired 4,536 non-qualified stock options with an exercise price of $76.32, which become exercisable on the date of the 2025 Annual Meeting of Stockholders and expire on March 7, 2034.
• Following these transactions, Stewart beneficially owns 3,304 shares of common stock, including 1,572 restricted stock units with deferred settlement.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director suggests confidence, but it's a routine transaction.

Positives

• The acquisition of stock and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates